Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows the revision label v3.6.6, replacing the previous v3.6.5. This indicates a new build of the site’s software rather than a content update.
    Difference
    0.1%
    Check dated 2026-08-29T23:45:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer updated the revision string from v3.6.4 to v3.6.5, representing a new version of the page.
    Difference
    0.1%
    Check dated 2026-08-08T22:20:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new page revision label, v3.6.4, appears, replacing the previous v3.6.3. This indicates a minor update to the page version or documentation.
    Difference
    0.1%
    Check dated 2026-07-25T13:04:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The revision label on the page changed to v3.6.3 from v3.6.2, indicating a small update to the document version.
    Difference
    0.1%
    Check dated 2026-07-04T04:41:28.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor system update to the page. It does not alter the study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-06-27T02:49:34.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Recruitment status now shows No longer looking for participants; new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was standardized, and the footer revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T14:58:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.